12,500 Shares in Avantor, Inc. (NYSE:AVTR) Bought by Symmetry Investments LP

Symmetry Investments LP purchased a new stake in Avantor, Inc. (NYSE:AVTR) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,500 shares of the company’s stock, valued at approximately $265,000.

A number of other hedge funds have also recently bought and sold shares of AVTR. Franklin Resources Inc. lifted its position in shares of Avantor by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,476,186 shares of the company’s stock worth $33,701,000 after buying an additional 11,592 shares during the period. Commerce Bank lifted its holdings in shares of Avantor by 52.3% during the fourth quarter. Commerce Bank now owns 30,209 shares of the company’s stock valued at $690,000 after acquiring an additional 10,370 shares during the period. TCW Group Inc. acquired a new stake in shares of Avantor in the 4th quarter valued at $237,000. Advisory Services Network LLC bought a new stake in shares of Avantor in the 4th quarter worth about $219,000. Finally, Nomura Asset Management Co. Ltd. grew its holdings in shares of Avantor by 6.8% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 173,829 shares of the company’s stock worth $3,969,000 after purchasing an additional 11,000 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Price Performance

Avantor stock opened at $26.99 on Friday. The business’s 50-day simple moving average is $25.04 and its 200 day simple moving average is $24.36. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. The stock has a market cap of $18.33 billion, a price-to-earnings ratio of 69.21, a P/E/G ratio of 2.75 and a beta of 1.32. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $28.00.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. As a group, research analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current year.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

AVTR has been the subject of several analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $31.00 price target on shares of Avantor in a report on Monday, July 29th. Stifel Nicolaus lifted their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Wells Fargo & Company initiated coverage on Avantor in a research report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 price target on the stock. Evercore ISI dropped their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Finally, TD Cowen boosted their price objective on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Avantor has an average rating of “Moderate Buy” and an average target price of $27.40.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.